The dermatitis control program for head and neck cancer patients treated with radiotherapy -prospective phase II study-

The dermatitis control program for head and neck cancer patients treated with radiotherapy -prospective phase II study- - Decop-01

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001579

Enrollment

120

Registered

2009-02-01

Start date

2009-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and neck cancer

Interventions

The dermatitis control program

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Head and neck cancer patients who are to be treated with RT 2.No prior treatment 3.PS(ECOG) 0-2 4.Written in IC

Exclusion criteria

Exclusion criteria: 1.With mental disorder 2.Recieve systemic streroid therapy

Design outcomes

Primary

Measure	Time frame
Frequency of grade 4 dermatitis	—

Secondary

Measure	Time frame
Frequency of grade 3 dermatitis Dermatitis recovery period	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026